← Back to Search

Intervention Strategies for Increasing HPV Vaccination Rates (HPV MISTICS Trial)

N/A

Recruiting

Led By Susan T Vadaparampil, PhD, MPH

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 5 years

Awards & highlights

HPV MISTICS Trial Summary

This trial will test an intervention to increase HPV vaccine rates among 11-17 year olds in 8 Florida health centers.

Who is the study for?

This trial is for English or Spanish-speaking parents of 11-17 year olds, healthcare providers, and staff at certain health centers in Florida. It's focused on those who have not started or completed the HPV vaccine series. Participants must be over 18 and interact with parents of adolescents who are eligible for the HPV vaccine.Check my eligibility

What is being tested?

The 'HPV MISTICS' study tests strategies to increase HPV vaccination rates among teens at community health centers. It involves different approaches targeting healthcare champions, parents, and providers to see which methods work best in promoting vaccinations.See study design

What are the potential side effects?

Since this trial focuses on intervention strategies rather than a medical product, it does not directly involve side effects from drugs or vaccines. However, there may be indirect effects related to changes in behavior or attitudes towards vaccination.

HPV MISTICS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effectiveness: HPV Vaccine series completion rates

Effectiveness: HPV Vaccine series initiation rates

Secondary outcome measures

Implementation outcome: Reach

Implementation outcome: Reach demographics

Intervention Sustainability: Health care Providers

+4 more

HPV MISTICS Trial Design

2Treatment groups

Experimental Treatment

Group I: Wave 2: Second Community Health CentersExperimental Treatment3 Interventions

Second group of community health centers to receive intervention

Group II: Wave 1: Initial Community Health CentersExperimental Treatment3 Interventions

Initial group of community health centers to receive intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor

542 Previous Clinical Trials

134,928 Total Patients Enrolled

1 Trials studying HPV Vaccines

155 Patients Enrolled for HPV Vaccines

Florida Department of HealthOTHER_GOV

28 Previous Clinical Trials

12,439 Total Patients Enrolled

Health Choice NetworkOTHER

5 Previous Clinical Trials

5,819,144 Total Patients Enrolled

Media Library

Wave 1: Initial Community Health Centers Clinical Trial Eligibility Overview. Trial Name: NCT05677360 — N/A

HPV Vaccines Research Study Groups: Wave 1: Initial Community Health Centers, Wave 2: Second Community Health Centers

HPV Vaccines Clinical Trial 2023: Wave 1: Initial Community Health Centers Highlights & Side Effects. Trial Name: NCT05677360 — N/A

Wave 1: Initial Community Health Centers 2023 Treatment Timeline for Medical Study. Trial Name: NCT05677360 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for participants in this experiment?

"Confirmed. Clinicaltrials.gov hosts records which demonstrate that this clinical trial, initially released on December 20th 2022, is actively seeking candidates. The researchers are hoping to admit 564 individuals from a single medical centre."

Answered by AI

How many individuals are included in this trial's cohort?

"Indeed, clinicaltrials.gov data confirms that the recruitment process for this medical trial is ongoing; it was initially reported on December 20th 2022 and last modified on January 9th 2023. The study requires 564 participants at one location to participate in order to be successful."

Answered by AI

What are the goals of this research experiment?

"This 5-year trial aims to measure the effectiveness of HPV vaccine series completion rates. It will also evaluate other implementation outcomes such as reach demographics, proportion of healthcare providers participating in the intervention, and proportions of these providers based on rural vs urban locations within Federally Qualified Health Centers' network."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

2023. "HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05677360.